1
|
Morgan R, Garrison-Desany H, Hobbs AJ, Wilson E. Strengthening effectiveness evaluations through gender integration to improve programs for women, newborn, child, and adolescent health. Glob Health Action 2022; 15:2006420. [PMID: 36098954 PMCID: PMC9481075 DOI: 10.1080/16549716.2021.2006420] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Over the past decade, there has been substantial progress towards integrating our understanding of social determinants of reproductive, maternal, newborn, child, and adolescent health (RMNCAH) into health planning and programs. For these programs, gender inequity remains one of the most harmful factors for women’s access to healthcare. Designing RMNCAH programs to be gender-responsive through active engagement with and overcoming of gender-related barriers remains paramount to increasing women’s access to and use of health programs. However, the integration of gender within RMNCAH programs and their evaluation is often non-existent or is limited in scope. Building on a prior framework for comprehensive gender analysis in RMNCAH, we discuss key steps used to incorporate a gender lens and analytical approach in the Real Accountability: Data Analysis for Results (RADAR) evaluation framework. In order to effectively address these key areas, gender must be integrated into all stages of the evaluation, including tool development and programmatic activities that are associated with each question. Our paper includes practical activities and tools that evaluators may use to integrate gender into their evaluation tools.
Collapse
Affiliation(s)
- Rosemary Morgan
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Henri Garrison-Desany
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Amy J Hobbs
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Emily Wilson
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| |
Collapse
|
2
|
Williams RS, Stetten NE, Cook C, Cook R, Ezenwa MO, Lucero R. The Meaning and Perceptions of HIV-Related Stigma in African American Women Living With HIV in Rural Florida: A Qualitative Study. J Assoc Nurses AIDS Care 2022; 33:118-131. [PMID: 33782240 PMCID: PMC9744244 DOI: 10.1097/jnc.0000000000000252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
ABSTRACT African Americans are disproportionally affected by HIV/AIDS compared with other races/ethnicities, yet few studies have examined the cultural and/or attitudinal precursors that can make African American women vulnerable to HIV-related stigma in the rural South. This study qualitatively explored the meaning and perceptions of HIV-related stigma among African American women in Florida. Thirteen semi-structured interviews were conducted using an empirical phenomenological approach. Five observer perspectives and 26 participant perspectives emerged. Participants described stigma through self-conceptualizations (e.g., ignorance), experiences (e.g., judgments), psychological dysfunction (e.g., mental health), intersectionality (e.g., race, disability), and overcoming stigma (e.g., advocacy). Our findings reveal that HIV-related stigma is unpleasant for African American women. However, over time, women in this study developed strategies to combat stigma. Elements of stigma reduction described in this study may be an important starting point for designing a culturally targeted intervention for African American women living with HIV.
Collapse
Affiliation(s)
- Renessa S. Williams
- Renessa S. Williams, PhD, RN, is a Postdoctoral Associate, Miller School of Medicine, Department of Surgery, University of Miami, Coral Gables, Florida, USA. Nichole E. Stetten, PhD, MPH, CPH, is a Research Assistant Professor, College of Public Health and Health Professions, Department of Occupational Therapy, University of Florida, Gainesville, Florida, USA. Christa Cook, PhD, RN, FAAN, is an Associate Professor, College of Nursing, University of Central Florida, Orlando, Florida, USA. Robert Cook, MD, MPH, is a Professor, College of Public Health and Health Professions & College of Medicine, Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Miriam O. Ezenwa, PhD, RN, FAAN, is an Associate Professor, College of Nursing, Department of Biobehavioral Nursing Science, University of Florida, Gainesville, Florida, USA. Robert Lucero, PhD, MPH, RN, FAAN, is an Associate Professor, College of Nursing, Department of Family, Community and Health Systems Science, University of Florida, Gainesville, Florida, USA
| | - Nichole E. Stetten
- Renessa S. Williams, PhD, RN, is a Postdoctoral Associate, Miller School of Medicine, Department of Surgery, University of Miami, Coral Gables, Florida, USA. Nichole E. Stetten, PhD, MPH, CPH, is a Research Assistant Professor, College of Public Health and Health Professions, Department of Occupational Therapy, University of Florida, Gainesville, Florida, USA. Christa Cook, PhD, RN, FAAN, is an Associate Professor, College of Nursing, University of Central Florida, Orlando, Florida, USA. Robert Cook, MD, MPH, is a Professor, College of Public Health and Health Professions & College of Medicine, Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Miriam O. Ezenwa, PhD, RN, FAAN, is an Associate Professor, College of Nursing, Department of Biobehavioral Nursing Science, University of Florida, Gainesville, Florida, USA. Robert Lucero, PhD, MPH, RN, FAAN, is an Associate Professor, College of Nursing, Department of Family, Community and Health Systems Science, University of Florida, Gainesville, Florida, USA
| | - Christa Cook
- Renessa S. Williams, PhD, RN, is a Postdoctoral Associate, Miller School of Medicine, Department of Surgery, University of Miami, Coral Gables, Florida, USA. Nichole E. Stetten, PhD, MPH, CPH, is a Research Assistant Professor, College of Public Health and Health Professions, Department of Occupational Therapy, University of Florida, Gainesville, Florida, USA. Christa Cook, PhD, RN, FAAN, is an Associate Professor, College of Nursing, University of Central Florida, Orlando, Florida, USA. Robert Cook, MD, MPH, is a Professor, College of Public Health and Health Professions & College of Medicine, Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Miriam O. Ezenwa, PhD, RN, FAAN, is an Associate Professor, College of Nursing, Department of Biobehavioral Nursing Science, University of Florida, Gainesville, Florida, USA. Robert Lucero, PhD, MPH, RN, FAAN, is an Associate Professor, College of Nursing, Department of Family, Community and Health Systems Science, University of Florida, Gainesville, Florida, USA
| | - Robert Cook
- Renessa S. Williams, PhD, RN, is a Postdoctoral Associate, Miller School of Medicine, Department of Surgery, University of Miami, Coral Gables, Florida, USA. Nichole E. Stetten, PhD, MPH, CPH, is a Research Assistant Professor, College of Public Health and Health Professions, Department of Occupational Therapy, University of Florida, Gainesville, Florida, USA. Christa Cook, PhD, RN, FAAN, is an Associate Professor, College of Nursing, University of Central Florida, Orlando, Florida, USA. Robert Cook, MD, MPH, is a Professor, College of Public Health and Health Professions & College of Medicine, Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Miriam O. Ezenwa, PhD, RN, FAAN, is an Associate Professor, College of Nursing, Department of Biobehavioral Nursing Science, University of Florida, Gainesville, Florida, USA. Robert Lucero, PhD, MPH, RN, FAAN, is an Associate Professor, College of Nursing, Department of Family, Community and Health Systems Science, University of Florida, Gainesville, Florida, USA
| | - Miriam O. Ezenwa
- Renessa S. Williams, PhD, RN, is a Postdoctoral Associate, Miller School of Medicine, Department of Surgery, University of Miami, Coral Gables, Florida, USA. Nichole E. Stetten, PhD, MPH, CPH, is a Research Assistant Professor, College of Public Health and Health Professions, Department of Occupational Therapy, University of Florida, Gainesville, Florida, USA. Christa Cook, PhD, RN, FAAN, is an Associate Professor, College of Nursing, University of Central Florida, Orlando, Florida, USA. Robert Cook, MD, MPH, is a Professor, College of Public Health and Health Professions & College of Medicine, Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Miriam O. Ezenwa, PhD, RN, FAAN, is an Associate Professor, College of Nursing, Department of Biobehavioral Nursing Science, University of Florida, Gainesville, Florida, USA. Robert Lucero, PhD, MPH, RN, FAAN, is an Associate Professor, College of Nursing, Department of Family, Community and Health Systems Science, University of Florida, Gainesville, Florida, USA
| | - Robert Lucero
- Renessa S. Williams, PhD, RN, is a Postdoctoral Associate, Miller School of Medicine, Department of Surgery, University of Miami, Coral Gables, Florida, USA. Nichole E. Stetten, PhD, MPH, CPH, is a Research Assistant Professor, College of Public Health and Health Professions, Department of Occupational Therapy, University of Florida, Gainesville, Florida, USA. Christa Cook, PhD, RN, FAAN, is an Associate Professor, College of Nursing, University of Central Florida, Orlando, Florida, USA. Robert Cook, MD, MPH, is a Professor, College of Public Health and Health Professions & College of Medicine, Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Miriam O. Ezenwa, PhD, RN, FAAN, is an Associate Professor, College of Nursing, Department of Biobehavioral Nursing Science, University of Florida, Gainesville, Florida, USA. Robert Lucero, PhD, MPH, RN, FAAN, is an Associate Professor, College of Nursing, Department of Family, Community and Health Systems Science, University of Florida, Gainesville, Florida, USA
| |
Collapse
|
3
|
Social determinants of health and self-rated health status: A comparison between women with HIV and women without HIV from the general population in Canada. PLoS One 2019; 14:e0213901. [PMID: 30897144 PMCID: PMC6428327 DOI: 10.1371/journal.pone.0213901] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2018] [Accepted: 03/04/2019] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Women living with HIV (WLWH) continue to experience poorer outcomes across the HIV care cascade and overall health, an appreciable proportion of which may not be disease-related but due to socio-structural barriers that impact health. We compared socio-structural determinants of health and self-rated health between WLWH and expected general population values. METHODS Prevalences of socio-structural determinants and self-rated health were estimated from 1,422 WLWH aged 16+ in the 2013-2015 Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS). Prevalences were also estimated from 46,831 general population women (assumed HIV-negative) in the 2013-2014 Canadian Community Health Survey (CCHS), standardized to the age/ethnoracial group distribution of WLWH. Standardized prevalence differences (SPDs) and 95% confidence intervals (CI) were reported. RESULTS Compared to general population women, a higher proportion of WLWH reported annual personal income <$20,000 (SPD 42.2%; 95% CI: 39.1, 45.2), indicating that 42.2% of WLWH experienced this low income, in excess of what would be expected of Canadian women of similar ages/ethnoracial backgrounds. A higher proportion of WLWH reported severe food insecurity (SPD 43.9%; 40.2, 47.5), poor perceived social support (SPD 27.4%; 22.2, 33.0), frequent racial (SPD 36.8%; 31.9, 41.8) and gender (SPD 46.0%; 42.6, 51.6) discrimination, and poor/fair self-rated health (SPD 12.2%; 9.4, 15.0). CONCLUSIONS Significant socio-structural inequalities and lower self-rated health were found among WLWH compared to general population women. Such inequities support the integration of a social-determinants approach, social service delivery, and programming into HIV care, with additional resource allocation tailored to the particular needs of WLWH.
Collapse
|
4
|
CHIN‐YEE BENJAMIN, SUBRAMANIAN S, VERMA AMOLA, LAUPACIS ANDREAS, RAZAK FAHAD. Emerging Trends in Clinical Research: With Implications for Population Health and Health Policy. Milbank Q 2018; 96:369-401. [PMID: 29870114 PMCID: PMC5987824 DOI: 10.1111/1468-0009.12328] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Policy Points: Significant advances in clinical medicine that have broader societal relevance may be less accessible to population health researchers and policymakers because of increased specialization within fields. We describe important recent clinical advances and discuss their broader societal impact. These advances include more expansive strategies for disease prevention, the rise of precision medicine, applications of human microbiome research, and new and highly successful treatments for hepatitis C infection. These recent developments in clinical research raise important issues surrounding health care costs and equitable resource allocation that necessitate an ongoing dialogue among the fields of clinical medicine, population health, and health policy. CONTEXT Developments in clinical medicine have important implications for population health, and there is a need for interdisciplinary engagement among clinical medicine, the social sciences, and public health research. The aim of this article is to help bridge the divide between these fields by exploring major recent advances in clinical medicine that have important implications for population health. METHODS We reviewed the most cited articles published from 2010 to 2015 in 5 high-impact clinical journals and selected 5 randomized controlled trials and 2 related clinical practice guidelines that are broadly relevant to population health and policy. FINDINGS We discuss the following themes: (1) expanding indications for drug therapy and the inherent medicalization of the population as highlighted by studies and clinical guidelines supporting lower blood pressure targets or widespread statin use; (2) the tension in nutritional research between quantifying the impact of isolated nutrients and studying specific foods and dietary patterns, for example, the role of the Mediterranean diet in the primary prevention of cardiovascular disease; (3) the issue of high medication costs and the challenge of providing equitable access raised by the development of new and effective treatments for hepatitis C infection; (4) emerging clinical applications of research on the human microbiome as illustrated by fecal transplant to treat Clostridium difficile infections; and (5) the promise and limitations of precision medicine as demonstrated by the rise of novel targeted therapies in oncology. CONCLUSIONS These developments in clinical science hold promise for improving individual and population health and raise important questions about resource allocation, the role of prevention, and health disparities.
Collapse
Affiliation(s)
| | - S.V. SUBRAMANIAN
- Harvard Center for Population and Development StudiesHarvard University
- Harvard T.H. Chan School of Public Health
| | - AMOL A. VERMA
- University of Toronto
- St. Michael's Hospital
- Li Ka Shing Knowledge InstituteSt. Michael's Hospital
| | - ANDREAS LAUPACIS
- University of Toronto
- St. Michael's Hospital
- Li Ka Shing Knowledge InstituteSt. Michael's Hospital
- Institute of Health Policy, Management and EvaluationUniversity of Toronto
| | - FAHAD RAZAK
- University of Toronto
- St. Michael's Hospital
- Harvard Center for Population and Development StudiesHarvard University
- Li Ka Shing Knowledge InstituteSt. Michael's Hospital
- Institute of Health Policy, Management and EvaluationUniversity of Toronto
| |
Collapse
|
5
|
Heywood W, Lyons A. Change in subjective social status following HIV diagnosis and associated effects on mental and physical health among HIV-positive gay men in Australia. Psychol Health 2017; 32:860-875. [PMID: 28343410 DOI: 10.1080/08870446.2017.1307374] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
OBJECTIVE This study investigates the impact of HIV diagnosis on subjective social status and if changes are linked to health outcomes. DESIGN Two measures of subjective social status, socio-economic and standing in the community were examined in 342 Australian HIV-positive gay men in 2014. Participants recalled ratings at diagnosis were compared with current ratings. MAIN OUTCOME MEASURES Self-reported mental (psychological distress, self-esteem, positive mental health and satisfaction with life) and physical health (self-rated health, CD4 count, viral load). RESULTS Half of the participants reported improvements in subjective socio-economic status (59%) or standing in the community (52%) since diagnosis, yet one quarter reported socio-economic status (25%) or standing in the community had decreased (23%). Increases in either measure of subjective social status were linked to higher self-esteem, positive mental health, satisfaction with life and better self-rated health. Decreases in subjective social status, however, were strongly linked to poorer outcomes on all mental health measures. Decreases in standing in the community were also associated with poorer physical self-rated health. CONCLUSION Most participants reported their subjective social status were the same or better since diagnosis. Changes in subjective social status following diagnosis were strongly linked to mental health outcomes. Those who reported a decrease in subjective social status were particularly vulnerable to mental health problems.
Collapse
Affiliation(s)
- Wendy Heywood
- a Australian Research Centre in Sex, Health and Society , School of Psychology and Public Health, La Trobe University , Melbourne , Australia
| | - Anthony Lyons
- a Australian Research Centre in Sex, Health and Society , School of Psychology and Public Health, La Trobe University , Melbourne , Australia
| |
Collapse
|
6
|
Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe. AIDS 2017; 31:835-846. [PMID: 28272136 DOI: 10.1097/qad.0000000000001411] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
BACKGROUND We evaluate differences in timing of cART (combined antiretroviral treatment) initiation by geographical origin in male and female HIV-positive patients in the Collaboration of Observational HIV Epidemiological Research Europe, a large European Collaboration of HIV Cohorts. METHODS We included individuals recruited in Western Europe between January 1997 and March 2013, with known geographical origin and at least 1 CD4 cell count measurement while cART-naive. Timing of cART was assessed through modified time-to-event methods, in which a scale of CD4 cell counts was used instead of time, with cART being the outcome. We estimated the median CD4 cell count at cART initiation (estimated CD4 levels at which the probability of having started cART is 50%) using Kaplan-Meier and adjusted hazard ratios of cART initiation using Cox regression. RESULTS Of 151 674 individuals, 110 592 (72.9%) were men. Median (95% confidence interval) CD4 cell count falls far below 250 cells/μl in all groups and was lowest in sub-Saharan African [SSA: 161 (158-167)], Caribbean men [161 (150-174)] and in Asian women [Asian Continent and Oceania: 185 (165-197)]. Among men, the adjusted probability of cART initiation was lower in migrants compared with natives, but differences depended on initial CD4 cell count. For example, in the group with more than 500 CD4 at recruitment, they were 45% (36-53%), 30% (17-40%) and 25% (19-30%) lower for Caribbean, Eastern European and SSA men, respectively. In women, no meaningful differences were observed between natives and most migrant groups. However, SSA women had a 31% (24-38%) higher probability of cART initiation when recruited at a CD4 more than 500 cells/μl and 9% (4-14%) lower when recruited at CD4 less than 100 cells/μl. CONCLUSION Most migrant men initiate cART at lower CD4 cell count than natives, whereas this does not hold for migrant women.
Collapse
|
7
|
Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe. AIDS 2017; 31:253-262. [PMID: 27662557 DOI: 10.1097/qad.0000000000001270] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
BACKGROUND Socioeconomic inequality challenges population-level implementation of health interventions. We investigated differences by educational level in clinical, virological, and immunological responses to combined antiretroviral treatment (cART) in HIV-positive men and women in Collaboration of Observational HIV Epidemiological Research in Europe, a European collaboration. METHODS Data were pooled from 15 cohorts in eight countries of patients initiating cART in 1996-2013 with data on educational level categorized in UNESCO/ISCED classifications. Kaplan-Meier curves, Cox and piecewise linear mixed models were used. RESULTS Of 24 069 HIV-positive patients, 9% had not completed primary education, 32% had completed primary, 44% secondary, and 15% tertiary education. Overall, 21% were women, who were overrepresented in lower educational strata. During 132 507 person-years of follow-up, 1081 individuals died; cumulative mortality decreased with higher educational level (P < 0.001). Over 122 765 person-years, new AIDS events or death occurred in 2598 individuals; differences by education were more marked than for death alone (P < 0.001). Virological response was achieved by 67% of patients without completed basic education, 85% with completed primary education, 82% with secondary, and 87% with tertiary (P < 0.001). Patients with higher education had higher CD4 cell count at cART initiation and at each time after cART but rate of CD4 cell count recovery did not differ. Differences in mortality and clinical responses were similar for men and women and were not entirely explained by delayed HIV diagnosis and late cART initiation. CONCLUSION HIV-positive patients with lower educational level had worse responses to cART and survival in European countries with universal healthcare. To maximize the population impact of cART, Europe needs to decrease the socioeconomic divide.
Collapse
|
8
|
Impact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in Vietnam. PLoS One 2016; 11:e0168687. [PMID: 28005937 PMCID: PMC5179124 DOI: 10.1371/journal.pone.0168687] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Accepted: 12/05/2016] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Ensuring an equal benefit across different patient groups is necessary while scaling up free-of-charge antiretroviral treatment (ART) services. This study aimed to measure the disparity in access, adherence, and outcomes of ART in Vietnam and the effects of socioeconomic status (SES) characteristics on the levels of inequality. METHODS A cross-sectional study was conducted in 1133 PLWH in Vietnam. ART access, adherence, and treatment outcomes were self-reported using a structured questionnaire. Wealth-related inequality was calculated using a concentration index, and a decomposition analysis was used to determine the contribution of each SES variable to inequality in access, adherence, and outcomes of ART. RESULTS Based on SES, minor inequality was found in ART access and adherence while there was considerable inequality in ART outcomes. Poor people were more likely to start treatment early, while rich people had better adherence and overall treatment outcomes. Decomposition revealed that occupation and education played important roles in inequality in ART access, adherence, and treatment outcomes. CONCLUSION The findings suggested that health services should be integrated into the ART regimen. Furthermore, occupational orientation and training courses should be provided to reduce inequality in ART access, adherence, and treatment outcomes.
Collapse
|
9
|
Etiaba E, Onwujekwe O, Torpey K, Uzochukwu B, Chiegil R. What Is the Economic Burden of Subsidized HIV/AIDS Treatment Services on Patients in Nigeria and Is This Burden Catastrophic to Households? PLoS One 2016; 11:e0167117. [PMID: 27911921 PMCID: PMC5135056 DOI: 10.1371/journal.pone.0167117] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2015] [Accepted: 11/09/2016] [Indexed: 11/23/2022] Open
Abstract
Background A gap in knowledge exists regarding the economic burden on households of subsidized anti-retroviral treatment (ART) programs in Nigeria. This is because patients also incur non-ART drug costs, which may constrain the delivery and utilisation of subsidized services. Methods An exit survey of adults (18+years) attending health facilities for HIV/AIDS treatment was conducted in three states in Nigeria (Adamawa, Akwa Ibom and Anambra). In the states, ART was fully subsidized but there were different payment modalities for other costs of treatment. Data was collected and analysed for direct and indirect costs of treatment of HIV/AIDS and co-morbidities’ during out-and in-patient visits. The levels of catastrophic health expenditure (CHE) were computed and disaggregated by state, socio-economic status (SES) and urban-rural location of the respondents. Catastrophic Health Expenditure (CHE) in this study measures the number of respondents whose monthly ART-related household expenditure (for in-patient and out-patient visits) as a proportion of monthly non-food expenditure was greater than 40% and 10% respectively. Results The average out-patient and in-patient direct costs were $5.49 and $122.10 respectively. Transportation cost was the highest non-medical cost and it was higher than most medical costs. The presence of co-morbidities contributed to household costs. All the costs were catastrophic to households at 10% and 40% thresholds in the three states, to varying degrees. The poorest SES quintile had the highest incidence of CHE for out-patient costs (p<0.0001). Rural dwellers incurred more CHE for all categories of costs compared to urban dwellers, but the costs were statistically significant for only outpatient costs. Conclusion ART subsidization is not enough to eliminate economic burden of treatment on HIV patients. Service decentralization to reduce travel costs, and subsidy on other components of HIV treatment services should be introduced to eliminate the persisting inequitable and high cost burden of ART services. Full inclusion of ART services within the benefit package of the National Health Insurance Scheme should be considered.
Collapse
Affiliation(s)
- Enyi Etiaba
- Department of Health Administration and Management, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
- Health Policy Research Group, Department of Pharmacology and Pharmaco-Therapeutics, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
- * E-mail:
| | - Obinna Onwujekwe
- Department of Health Administration and Management, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
- Health Policy Research Group, Department of Pharmacology and Pharmaco-Therapeutics, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
| | - Kwasi Torpey
- Strengthening Integrated delivery for HIV/AIDS services (SIDHAS), FHI 360, Plot 1073 J.S. Tarka Street, Garki, P.M.B, Abuja, Nigeria
| | - Benjamin Uzochukwu
- Department of Health Administration and Management, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
- Health Policy Research Group, Department of Pharmacology and Pharmaco-Therapeutics, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
- Department of Community Medicine, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
| | - Robert Chiegil
- Strengthening Integrated delivery for HIV/AIDS services (SIDHAS), FHI 360, Plot 1073 J.S. Tarka Street, Garki, P.M.B, Abuja, Nigeria
| |
Collapse
|
10
|
Mocroft A, Lundgren J, Antinori A, Monforte AD, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. ACTA ACUST UNITED AC 2016; 20:30070. [PMID: 26624933 DOI: 10.2807/1560-7917.es.2015.20.47.30070] [Citation(s) in RCA: 60] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Accepted: 11/18/2015] [Indexed: 11/20/2022]
Abstract
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-European update from 34 countries on the prevalence and risk factors of LP for 2010-2013. People aged ≥ 16 presenting for HIV care (earliest of HIV-diagnosis, first clinic visit or cohort enrollment) after 1 January 2010 with available CD4 count within six months of presentation were included. LP was defined as presentation with a CD4 count < 350/mm(3) or an AIDS defining event (at any CD4), in the six months following HIV diagnosis. Logistic regression investigated changes in LP over time. A total of 30,454 people were included. The median CD4 count at presentation was 368/mm(3) (interquartile range (IQR) 193-555/mm(3)), with no change over time (p = 0.70). In 2010, 4,775/10,766 (47.5%) were LP whereas in 2013, 1,642/3,375 (48.7%) were LP (p = 0.63). LP was most common in central Europe (4,791/9,625, 49.8%), followed by northern (5,704/11,692; 48.8%), southern (3,550/7,760; 45.8%) and eastern Europe (541/1,377; 38.3%; p < 0.0001). There was a significant increase in LP in male and female people who inject drugs (PWID) (adjusted odds ratio (aOR)/year later 1.16; 95% confidence interval (CI): 1.02-1.32), and a significant decline in LP in northern Europe (aOR/year later 0.89; 95% CI: 0.85-0.94). Further improvements in effective HIV testing strategies, with a focus on vulnerable groups, are required across the European continent.
Collapse
|
11
|
Monge S, Pérez-Molina JA. [HIV infection and immigration]. Enferm Infecc Microbiol Clin 2016; 34:431-8. [PMID: 27016136 DOI: 10.1016/j.eimc.2016.02.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2016] [Accepted: 02/22/2016] [Indexed: 11/26/2022]
Abstract
Migrants represent around one third of patients newly diagnosed with HIV in Spain and they constitute a population with higher vulnerability to its negative consequences due to the socio-cultural, economical, working, administrative and legal contexts. Migrants are diagnosed later, which worsens their individual prognosis and facilitates the maintenance of the HIV epidemic. In spite of the different barriers they experience to access healthcare in general, and HIV-related services in particular, access to antiretroviral treatment has been similar to that of the autochthonous population. However, benefits of treatment have been not, with women in general and men from Sub-Saharan Africa exhibiting the worse response to treatment. We need to proactively promote earlier diagnosis of HIV infection, the adoption of preventive measures to avoid new infections, and to deliver accessible, adapted and high-quality health-care.
Collapse
Affiliation(s)
- Susana Monge
- Facultad de Medicina, Universidad de Alcalá de Henares; CIBERESP, Madrid, España.
| | - José A Pérez-Molina
- CSUR de Medicina Tropical, Servicio de Enfermedades Infecciosas, Hospital Ramón y Cajal; IRYCIS, Madrid, España
| |
Collapse
|
12
|
Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative cohort study. Lancet HIV 2015; 2:e540-9. [PMID: 26614968 DOI: 10.1016/s2352-3018(15)00203-9] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Revised: 09/21/2015] [Accepted: 09/28/2015] [Indexed: 11/30/2022]
Abstract
BACKGROUND Many migrants face adverse socioeconomic conditions and barriers to health services that can impair timely HIV diagnosis and access to life-saving treatments. We aimed to assess the differences in overall mortality by geographical origin in HIV-positive men and women using data from COHERE, a large European collaboration of HIV cohorts from 1997 to 2013. METHODS In this observational cohort study, we included HIV-positive, antiretroviral-naive people accessing care in western Europe from COHERE. Individuals were eligible if enrolled in a cohort that collected information on geographical origin or ethnic origin from Jan 1, 1997, to March 19, 2013, aged 18-75 years, they had available information about sex, they were not infected perinatally or after the receipt of clotting factor concentrates, and were naive to combination antiretroviral therapy at cohort entry. Migrants' origins were grouped into seven regions: western Europe and similar countries (Australia, Canada, New Zealand, and the USA); eastern Europe; North Africa and the Middle East; sub-Saharan Africa; Latin America; the Caribbean; and Asia and the rest of Oceania (excluding Australia and New Zealand). Crude and adjusted mortality rate ratios were calculated by use of Poisson regression stratified by sex, comparing each group with the native population. Multiple imputation with chained equations was used to account for missing values. FINDINGS Between Oct 25, 1979, and March 19, 2013, we recruited 279 659 individuals to the COHERE collaboration in EuroCoord. Of these 123 344 men and 45 877 women met the inclusion criteria. Our data suggested effect modification by transmission route (pinteraction=0·12 for men; pinteraction=0·002 for women). No significant difference in mortality was identified by geographical origin in men who have sex with men. In heterosexual populations, most migrant men had mortality lower than or equal to that of native men, whereas no group of migrant women had mortality lower than that in native women. High mortality was identified in heterosexual men from Latin America (rate ratio [RR] 1·46, 95% CI 1·00-2·12, p=0·049) and heterosexual women from the Caribbean (1·48, 1·29-1·70, p<0·0001). Compared with that in the native population, mortality in injecting drug users was similar or low for all migrant groups. INTERPRETATION Characteristics of and risks faced by migrant populations with HIV differ for men and women and for populations infected heterosexually, by sex between men, or by injecting drug use. Further research is needed to understand how inequalities are generated and maintained for the groups with higher mortality identified in this study. FUNDING EuroCoord.
Collapse
|
13
|
Li M, Zhu Q, Zheng W, Pan P, Liang H, Ye L, Wang X, Zhu J, Li G, Dong B. A retrospective cohort study on the mortality of AIDS patients in Guangxi, China (2001-2011). AIDS Res Hum Retroviruses 2015; 31:439-47. [PMID: 25420616 DOI: 10.1089/aid.2014.0148] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The purpose of this article is to describe mortality trends in different highly active antiretroviral therapy (HAART) periods and associated factors among AIDS patients in Guangxi, China. We prospectively analyzed AIDS patients in Guangxi between 2001 and 2011; demographic characteristics were compared among AIDS patients diagnosed in three treatment periods (pre-HAART: 2001-2004, early-HAART: 2005-2008, and late-HAART: 2009-2011). AIDS mortality was calculated by person-years, and treatment coverage was defined as the proportion of time that patients who were eligible for treatment received treatment. Factors of AIDS mortality were determined by a Cox proportional hazard regression. Of 19,020 AIDS patients, overall mortality declined from 41.1 per 100 person-years in 2001 to 13.3 per 100 person-years in 2011 with treatment coverage increasing from zero to 72.1%. The overall median survival figure was 5.6 years (95% CI: 4.4-6.8) with 60.3% for 5-year survival rate. After AIDS diagnosis, the mortality rate peaked in the first year, and 37.4% patients were still active in the ninth year. Protective factors for mortality were AIDS patients diagnosed from 2009 to 2011 (AHR=0.75, 95% CI: 0.58-0.89), having received HAART (AHR=0.71, 95% CI: 0.50-0.87), and having a CD4 count of higher than 350 cells/μl at AIDS diagnosis (AHR=0.79, 95% CI: 0.60-0.92). Risk factors for mortality included being male (AHR=1.28, 95% CI: 1.07-1.43), living in a rural area (AHR=1.40, 95% CI: 1.18-1.94), and being aged ≥60 years at AIDS diagnosis (AHR=1.36, 95% CI: 1.18-1.73). A decline in AIDS mortality was observed in Guangxi with a concomitant increase in treatment coverage. Some subpopulations of AIDS patients, such as males, rural residents, and the old, require more medical care.
Collapse
Affiliation(s)
- Mingli Li
- School of Public Health, Guangxi Medical University, Nanning, Guangxi, China
- Institute for HIV/AIDS Control and Prevention, Guangxi Zhuang Autonomous Regional Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Qiuying Zhu
- Institute for HIV/AIDS Control and Prevention, Guangxi Zhuang Autonomous Regional Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Wenbin Zheng
- Project Department, Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, China
| | - Peijiang Pan
- School of Public Health, Guangxi Medical University, Nanning, Guangxi, China
- Guangxi Key Laboratory of AIDS Prevention and Treatment, Guangxi Medical University, Nanning, Guangxi, China
| | - Hao Liang
- School of Public Health, Guangxi Medical University, Nanning, Guangxi, China
- Guangxi Key Laboratory of AIDS Prevention and Treatment, Guangxi Medical University, Nanning, Guangxi, China
| | - Li Ye
- School of Public Health, Guangxi Medical University, Nanning, Guangxi, China
- Guangxi Key Laboratory of AIDS Prevention and Treatment, Guangxi Medical University, Nanning, Guangxi, China
| | - Xiaofang Wang
- National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Jinhui Zhu
- Institute for HIV/AIDS Control and Prevention, Guangxi Zhuang Autonomous Regional Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Guojian Li
- Health and Family Planning Commission of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
| | - Baiqing Dong
- School of Public Health, Guangxi Medical University, Nanning, Guangxi, China
- Health and Family Planning Commission of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
| |
Collapse
|
14
|
Wagener MN, van Opstal SEM, Miedema HS, Brandjes DPM, Dahmen R, van Gorp ECM, Roelofs PDDM. Employment-related concerns of HIV-positive people in the Netherlands: input for a multidisciplinary guideline. JOURNAL OF OCCUPATIONAL REHABILITATION 2014; 24:790-797. [PMID: 24806772 DOI: 10.1007/s10926-014-9510-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
PURPOSE Finding and keeping employment is difficult for people with HIV. To improve supportive care for people with HIV and employment-related problems, a multidisciplinary guideline was developed in the Netherlands in 2010/2011. To identify the employment-related concerns of people with HIV and to formulate the key questions for the guideline, we conducted a qualitative study. The results of this study are described in this article. METHODS This study was performed in three HIV-treatment centers in the Netherlands. In total 18 participants participated in three focus-group interviews and nine participants were interviewed individually. The data were transcribed ad verbatim and were analyzed according to the principle of constant comparison. RESULTS Our findings indicate that people with HIV in the Netherlands face many work-related concerns. The themes which emerged from this study were disclosure, stigma and discrimination, knowledge about HIV, physical and psychological factors, working conditions, absenteeism, reintegration, and dismissal and counselling. CONCLUSIONS This study provides insight into employment-related concerns for people with HIV living in a Western country. It formed the basis for the key questions which were addressed in a multidisciplinary, evidence-based guideline "HIV and work". Finally, it gives leads for further scientific research and opportunities for improving the vocational guidance of people with HIV.
Collapse
Affiliation(s)
- M N Wagener
- Research Centre Innovations in Care, Rotterdam University of Applied Sciences, P.O. Box 25035, 3001 HA, Rotterdam, The Netherlands,
| | | | | | | | | | | | | |
Collapse
|
15
|
Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord. AIDS 2014; 28:2297-306. [PMID: 25313585 DOI: 10.1097/qad.0000000000000410] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES In Europe and elsewhere, health inequalities among HIV-positive individuals are of concern. We investigated late HIV diagnosis and late initiation of combination antiretroviral therapy (cART) by educational level, a proxy of socioeconomic position. DESIGN AND METHODS We used data from nine HIV cohorts within COHERE in Austria, France, Greece, Italy, Spain and Switzerland, collecting data on level of education in categories of the UNESCO/International Standard Classification of Education standard classification: non-completed basic, basic, secondary and tertiary education. We included individuals diagnosed with HIV between 1996 and 2011, aged at least 16 years, with known educational level and at least one CD4 cell count within 6 months of HIV diagnosis. We examined trends by education level in presentation with advanced HIV disease (AHD) (CD4 <200 cells/μl or AIDS within 6 months) using logistic regression, and distribution of CD4 cell count at cART initiation overall and among presenters without AHD using median regression. RESULTS Among 15 414 individuals, 52, 45,37, and 31% with uncompleted basic, basic, secondary and tertiary education, respectively, presented with AHD (P trend <0.001). Compared to patients with tertiary education, adjusted odds ratios of AHD were 1.72 (95% confidence interval 1.48-2.00) for uncompleted basic, 1.39 (1.24-1.56) for basic and 1.20 (1.08-1.34) for secondary education (P < 0.001). In unadjusted and adjusted analyses, median CD4 cell count at cART initiation was lower with poorer educational level. CONCLUSIONS Socioeconomic inequalities in delayed HIV diagnosis and initiation of cART are present in European countries with universal healthcare systems and individuals with lower educational level do not equally benefit from timely cART initiation.
Collapse
|
16
|
Wagener MN, Roelofs P, Miedema HS, Brandjes DPM, Dahmen R, van Gorp ECM. The development of a multidisciplinary, evidence-based guideline for "HIV and employment". AIDS Care 2014; 27:133-41. [PMID: 25187184 DOI: 10.1080/09540121.2014.952612] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
The objective of this study was to develop a multidisciplinary guideline that supports the care and vocational rehabilitation of HIV-infected people with employment-related problems. The guideline was developed according to the "evidence-based guideline development" method developed by the Dutch Institute for Health Care Improvement. This method consists of the following steps: forming a multidisciplinary core group and an expert panel, formulating key questions, searching and appraising the available literature, formulating considerations and recommendations, peer reviewing the draft guideline, and authorizing the final guideline. All relevant professional associations were represented in the core group that was assembled to develop the guideline, i.e., HIV doctors, HIV nurses, general practitioners, occupational health physicians, psychologists, social workers, occupational health nurses, vocational experts, and insurance physicians. Five key questions for the guideline were formulated with the following themes: determinants of employment, disclosure and stigma, self-management, interventions, and the organization of care. In the literature review on these topics, 45 studies met the inclusion criteria. The methodological quality of the included articles was poor. Factors such as patient preferences and medical/ethical issues were considered. The recommendations in the guideline are a weighting of the scientific evidence and the considerations of the core group. The guideline, as well as its summary for daily practice, clarifies the most important barriers and facilitators to people with HIV either staying at work or returning to work, and it constitutes a clinical, easy-to-use guideline for health-care providers and how they can support people with HIV who want to work.
Collapse
Affiliation(s)
-
- a Research Centre Innovations in Care , Rotterdam University of Applied Science , Rotterdam , The Netherlands
| | | | | | | | | | | | | |
Collapse
|
17
|
Westerling R, Westin M, McKee M, Hoffmann R, Plug I, Rey G, Jougla E, Lang K, Pärna K, Alfonso JL, Mackenbach JP. The timing of introduction of pharmaceutical innovations in seven European countries. J Eval Clin Pract 2014; 20:301-10. [PMID: 24750393 PMCID: PMC4282430 DOI: 10.1111/jep.12122] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/10/2014] [Indexed: 11/28/2022]
Abstract
RATIONALE, AIMS AND OBJECTIVES Differences in the performance of medical care may be due to variation in the introduction and diffusion of medical innovations. The objective of this paper is to compare seven European countries (United Kingdom, the Netherlands, West Germany, France, Spain, Estonia and Sweden) with regard to the year of introduction of six specific pharmaceutical innovations (antiretroviral drugs, cimetidine, tamoxifen, cisplatin, oxalaplatin and cyclosporin) that may have had important population health impacts. METHODS We collected information on introduction and further diffusion of drugs using searches in the national and international literature, and questionnaires to national informants. We combined various sources of information, both official years of registration and other indicators of introduction (clinical trials, guidelines, evaluation reports, sales statistics). RESULTS AND CONCLUSIONS The total length of the period between first and last introduction varied between 8 years for antiretroviral drugs and 22 years for cisplatin. Introduction in Estonia was generally delayed until the 1990s. The average time lags were smallest in France (2.2 years), United Kingdom (2.8 years) and the Netherlands (3.5 years). Similar rank orders were seen for year of registration suggesting that introduction lags are not only explained by differences in the process of registration. We discuss possible reasons for these between-country differences and implications for the evaluation of medical care.
Collapse
Affiliation(s)
| | - Marcus Westin
- Research Physician, Department of Public Health and caring sciences, Social Medicine, Uppsala University, BMCUppsala, Sweden
| | - Martin McKee
- Professor, London School of Hygiene & Tropical MedicineLondon, UK
| | | | | | - Grégoire Rey
- Director, INSERM CépiDc44, chemin de Ronde, Paris, France
| | - Eric Jougla
- Director, INSERM CépiDc44, chemin de Ronde, Paris, France
| | - Katrin Lang
- Associate Professor, Department of Public Health, University of TartuTartu, Estonia
| | - Kersti Pärna
- Associate Professor, Department of Public Health, University of TartuTartu, Estonia
| | - José L Alfonso
- Professor, Department of Preventive Medicine and Public Health, University of ValenciaValencia, Spain
| | - Johan P Mackenbach
- Professor, Department of Public Health, Erasmus Medical CenterRotterdam, The Netherlands
| |
Collapse
|
18
|
Cohen GM, Werner L, Gengiah S, Naidoo K. Role of Education in HIV Clinical Outcomes in a Tuberculosis Endemic Setting. J Int Assoc Provid AIDS Care 2013; 13:402-8. [PMID: 23708680 DOI: 10.1177/2325957413488185] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
This study evaluated how educational attainment impacts clinical outcomes of HIV-positive patients in Durban, South Africa. The authors conducted a prospective study of 466 adult HIV-positive patients initiating antiretroviral therapy (ART) at an urban TB-HIV clinic from October 2004 to June 2007. The level of educational attainment (highest grade completed) was assessed at ART initiation. The authors measured tuberculosis treatment outcomes as well as death, lost to follow-up, viral suppression (HIV RNA <400 copies/mL), and immunologic response (CD4 ≥200 cells/mm(3)) at 6, 12, and 24 months after ART initiation. After 24 months of ART initiation, there were 43 deaths; viral suppression and immunologic response were observed in 88% and 83% of the remaining patients, respectively. The authors found no association between level of educational attainment and mortality (P = .12), loss to follow-up (P = .85), virologic response (P = .51), or immunologic response (P = .63). Similar findings were observed at 6 and 12 months post-ART initiation.
Collapse
Affiliation(s)
- Gabriel M Cohen
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa New York University School of Medicine, New York, NY, USA
| | - Lise Werner
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Santhanalakshmi Gengiah
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Kogieleum Naidoo
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| |
Collapse
|
19
|
Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain. HIV Med 2012; 14:273-83. [DOI: 10.1111/hiv.12001] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/09/2012] [Indexed: 11/29/2022]
Affiliation(s)
- S Monge
- AIDS Research Network; National Centre of Epidemiology; Carlos III Health Institute; Madrid; Spain
| | - B Alejos
- AIDS Research Network; National Centre of Epidemiology; Carlos III Health Institute; Madrid; Spain
| | - F Dronda
- Ramón y Cajal University Hospital; Madrid; Spain
| | | | | | - F Pulido
- 12 de Octubre University Hospital; Madrid; Spain
| | - R Rubio
- 12 de Octubre University Hospital; Madrid; Spain
| | - JM Miró
- Hospital Clinic - IDIBAPS; University of Barcelona; Barcelona; Spain
| | | | - J Del Amo
- AIDS Research Network; National Centre of Epidemiology; Carlos III Health Institute; Madrid; Spain
| | | |
Collapse
|
20
|
Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease. AIDS Res Treat 2012; 2012:169645. [PMID: 23091708 PMCID: PMC3471390 DOI: 10.1155/2012/169645] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2012] [Revised: 09/06/2012] [Accepted: 09/07/2012] [Indexed: 11/29/2022] Open
Abstract
Persons living with human immunodeficiency virus (HIV) are living longer; therefore, they are more likely to suffer significant morbidity due to potentially treatable liver diseases. Clinical evidence suggests that the growing number of individuals living with HIV and liver disease may have a poorer health-related quality of life (HRQOL) than persons living with HIV who do not have comorbid liver disease. Thus, this study examined the multiple components of HRQOL by testing Wilson and Cleary's model in a sample of 532 individuals (305 persons with HIV and 227 persons living with HIV and liver disease) using structural equation modeling. The model components include biological/physiological factors (HIV viral load, CD4 counts), symptom status (Beck Depression Inventory II and the Medical Outcomes Study HIV Health Survey (MOS-HIV) mental function), functional status (missed appointments and MOS-HIV physical function), general health perceptions (perceived burden visual analogue scale and MOS-HIV health transition), and overall quality of life (QOL) (Satisfaction with Life Scale and MOS-HIV overall QOL). The Wilson and Cleary model was found to be useful in linking clinical indicators to patient-related outcomes. The findings provide the foundation for development and future testing of targeted biobehavioral nursing interventions to improve HRQOL in persons living with HIV and liver disease.
Collapse
|
21
|
Pérez-Molina JA, Pulido Ortega F. [Assessment of the impact of the new health legislation on illegal immigrants in Spain: the case of human immunodeficiency virus infection]. Enferm Infecc Microbiol Clin 2012; 30:472-8. [PMID: 22939565 DOI: 10.1016/j.eimc.2012.07.004] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2012] [Revised: 07/15/2012] [Accepted: 07/17/2012] [Indexed: 12/17/2022]
Abstract
The immigrant population in Spain, whether legal or not, has been entitled to healthcare under the same conditions as the Spanish population since the year 2000. The entry into vigour of the Royal Decree-Law 12/2012 of 20 April has significantly restricted this right, so that unauthorized or non-resident foreigners may now only receive emergency care, if they are under 18 or pregnant women. Out of an estimated 459,909 illegal immigrants in our country, 2,700 to 4,600 are probably infected with HIV; 1,800 to 3,220 know that they are infected, and 80% of the latter could receive antiretroviral treatment. The Royal Decree-Law is likely to cause many undesirable consequences in this population infected with HIV: increasing mortality, promoting the emergence of opportunistic diseases, increasing hospital admissions, increasing infections in the population (by HIV and other pathogens), or contributing to mother to child transmission of HIV. The expected increase in morbidity and mortality will be a greater cost in patient care, a cost which will be significantly higher in the more immunosuppressed patients. Therefore, the enforcement of the Royal Decree-Law will be much less cost-effective in the short term than was expected, and will negatively affect our country's public health, especially for those patients infected with HIV who will not be covered, thus increasing healthcare medium to long term costs, and moving away from the international health goals that were established.
Collapse
Affiliation(s)
- José A Pérez-Molina
- Medicina Tropical, Servicio de Enfermedades Infecciosas, Hospital Ramon y Cajal, Madrid.
| | | | | |
Collapse
|
22
|
Zubaran C, Michelim L, Medeiros G, May W, Foresti K, Madi JM. A randomized controlled trial of a protocol of interviews designed to improve adherence to antiretroviral medications in southern Brazil. Int J STD AIDS 2012; 23:429-34. [DOI: 10.1258/ijsa.2011.011268] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The aim of this study was to evaluate the efficacy of the Portuguese version of the Medication Adherence Training Instrument (MATI) for improving adherence to antiretroviral therapy (ART) in southern Brazil. Two different follow-up modalities were compared in this 225 days randomized controlled study: one based on the MATI protocol and a conventional (non-MATI) clinical follow-up. There were no differences between the groups with the exception of socioeconomic class ( P < 0.005). The mean length of continuance in treatment was 111.4 (SD = 13.9) and 137.6 (SD = 17.3) days in the MATI and non-MATI groups, respectively. A Mantel–Cox log-rank test revealed no significant difference between the two interventions ( P = 0.34). Despite the sample size limitation, the results from this study indicate that the Portuguese version of the MATI was not more efficacious than the regular follow-up intervention for improving adherence of outpatients to ART.
Collapse
Affiliation(s)
- C Zubaran
- School of Medicine, University of Western Sydney
- Department of Psychiatry, Western Sydney Local Health District, Sydney, Australia
- School of Medicine, University of Caxias do Sul, Caxias do Sul, Brazil
| | - L Michelim
- School of Medicine, University of Caxias do Sul, Caxias do Sul, Brazil
| | - G Medeiros
- School of Medicine, University of Caxias do Sul, Caxias do Sul, Brazil
| | - W May
- School of Medicine, University of Caxias do Sul, Caxias do Sul, Brazil
| | - K Foresti
- Department of Psychiatry, Western Sydney Local Health District, Sydney, Australia
- School of Medicine, University of Caxias do Sul, Caxias do Sul, Brazil
| | - J M Madi
- School of Medicine, University of Caxias do Sul, Caxias do Sul, Brazil
| | | |
Collapse
|
23
|
Worthington C, O'Brien K, Zack E, McKee E, Oliver B. Enhancing labour force participation for people living with HIV: a multi-perspective summary of the research evidence. AIDS Behav 2012; 16:231-43. [PMID: 21701906 DOI: 10.1007/s10461-011-9986-y] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Labour force participation has been identified as a critical social and health issue facing people living with HIV/AIDS (PHAs). We conducted a scoping study (a form of literature synthesis that summarizes research findings, research activity, and identifies literature strengths and gaps) on labour force participation for PHAs, guided by a community advisory committee. We summarized information from 243 peer-reviewed articles and 42 reports from the grey literature, and synthesized the evidence into a preliminary conceptual framework with five components: (1) the meaning of work, (2) key factors (barriers and facilitators) influencing labour force participation, (3) factors affecting vulnerable populations, (4) strategies and supports for returning to or sustaining work, and (5) outcomes (benefits and risks) of labour force participation for individuals and employers. The framework supports the development of labour force initiatives requiring collaborative efforts in multiple domains (health, employment, community) by PHAs, rehabilitation professionals, employers, insurers, and policy makers.
Collapse
|
24
|
Lapostolle A, Massari V, Chauvin P. Time since the last HIV test and migration origin in the Paris metropolitan area, France. AIDS Care 2011; 23:1117-27. [PMID: 21500026 PMCID: PMC3472401 DOI: 10.1080/09540121.2011.554522] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
In France, the newly diagnosed infection rate was 372/100,000 for African immigrants versus 6/100,000 for the French-born population in 2008. In addition, people from sub-Saharan countries were at higher risk for late diagnosis than native-born French despite their more frequent use of HIV testing. The purpose of this study was to compare the mean time since the last HIV test according to migration origin. This study used data from the SIRS (a French acronym for health, inequalities, and social ruptures) cohort, which, in 2005, included 3023 households representative of the greater Paris area. HIV testing uptake and the time since the last test were studied in relation to socio-economic factors, psychosocial characteristics, and migration origin. Multivariate ANOVA analyses were performed using Stata 10. People from sub-Saharan Africa were more likely to have been tested in their lifetime (78.51%) than those of French (56.19%) or Maghreb (39.74%) origin (p<0.0000). The mean time, in years, since the last HIV test was shorter among sub-Saharan immigrants and Maghreb immigrants (2.15 and 2.53 years, respectively) than among native-born French (4.84 years) (F=12.67; p<0.0000). These differences remained significant even after adjusting for gender, age, number of steady relationships, time lived in France, and difficulty reading and/or writing French (F=5.73; p=0.0007). A gender analysis revealed the same pattern for both sexes, with greater differences in the mean duration by migration origin for women. These results and recent epidemiological data seem to show that since the early 2000s, measures aimed at increasing HIV testing and decreasing late diagnosis in sub-Saharan immigrants have been effective.
Collapse
|
25
|
Home is where the HAART is: an examination of factors affecting neighbourhood perceptions among people with HIV/AIDS on antiretroviral therapy. AIDS Care 2011; 23:245-51. [DOI: 10.1080/09540121.2010.490256] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
26
|
Sobrino-Vegas P, Rodríguez-Urrego J, Berenguer J, Caro-Murillo AM, Blanco JR, Viciana P, Moreno S, Bernardino I, del Amo J. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir Ther 2011; 17:1-8. [DOI: 10.3851/imp1939] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
27
|
Kitajima T, Kobayashi Y, Chaipah W, Sato H, Toyokawa S, Chadbunchachai W, Thuennadee R. Access to antiretroviral therapy among HIV/AIDS patients in khon kaen province, Thailand. AIDS Care 2010; 17:359-66. [PMID: 15832884 DOI: 10.1080/09540120512331314330] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
This study attempted to identify the factors associated with the access to antiretroviral therapy (ARV) among HIV/AIDS patients in Khon Kaen Province, Thailand. We collected medical and sociodemographic data from the medical charts of adult patients living in the province who received medical services at two public hospitals in the province. The study period was from December 1, 2001 to February 28, 2002. Total 593 outpatients were included in the analysis. One hundred and forty-six patients (24.6%) received ARV. A logistic regression analysis was conducted to identify the factors associated with the use of ARV. Patients who were covered by the Civil Servant Medical Benefit Scheme were significantly more likely to receive ARV than those who were covered by the Universal Coverage Scheme (UC), a publicly-funded medical insurance (OR = 12.43; 95% CI = 6.03-25.62). The results of this study indicated that there were inequalities in access to and use of ARV among HIV/AIDS patients by health insurance status. The current government announced that they would include ARV in the benefits package of UC. It would be important to monitor how this policy will improve the access to ARV among HIV/AIDS patients.
Collapse
Affiliation(s)
- T Kitajima
- Faculty of General Policy Studies, Kyorin University, Tokyo, Japan.
| | | | | | | | | | | | | |
Collapse
|
28
|
Burris S, Anderson ED. A framework convention on global health: social justice lite, or a light on social justice? THE JOURNAL OF LAW, MEDICINE & ETHICS : A JOURNAL OF THE AMERICAN SOCIETY OF LAW, MEDICINE & ETHICS 2010; 38:580-593. [PMID: 20880242 DOI: 10.1111/j.1748-720x.2010.00513.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
With the publication of the final report of the WHO Commission on the Social Determinants of Health, it becomes clear that there is considerable convergence between a policy agenda rooted on social epidemiology and one rooted in a concern for human rights. As commentators like Jonathan Mann have argued, concern for human rights and the achievement of social justice can inform and improve public health. In this article, we ask a different question: what does a health perspective adds to the enduring fight for a more just world? We consider three possibilities: (1) that public health, in an inversion of Mann's argument, actually provides useful tools for specifying social injustice; (2) that, contrary to the usual critical stance and assumption of weakness, the institutions of public health bring powerful capacities to the practical promotion of social justice; and (3) that health as a banner mobilizes people who would not be mobilized to act in the name of social justice.
Collapse
Affiliation(s)
- Scott Burris
- Center for Health Law, Policy and Practice, Temple University Beasley School of Law
| | | |
Collapse
|
29
|
From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav 2009; 13:1160-77. [PMID: 19636699 DOI: 10.1007/s10461-009-9593-3] [Citation(s) in RCA: 749] [Impact Index Per Article: 49.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2008] [Accepted: 07/12/2009] [Indexed: 10/20/2022]
Abstract
Recent analyses suggest that lack of clarity in the conceptualization and measurement of HIV stigma at an individual level is a significant barrier to HIV prevention and treatment efforts. In order to address this concern, we articulate a new framework designed to aid in clarifying the conceptualization and measurement of HIV stigma among individuals. The HIV Stigma Framework explores how the stigma of HIV elicits a series of stigma mechanisms, which in turn lead to deleterious outcomes for HIV uninfected and infected people. We then apply this framework to review measures developed to gauge the effect of HIV stigma since the beginning of the epidemic. Finally, we emphasize the utility of using three questions to guide future HIV stigma research: who is affected by, how are they affected by, and what are the outcomes of HIV stigma?
Collapse
|
30
|
Caro-Murillo AM, Castilla Catalán J, del Amo Valero J. [Epidemiology of HIV infection in immigrants in Spain: information sources, characteristics, magnitude and tendencies]. GACETA SANITARIA 2009; 24:81-8. [PMID: 19945771 DOI: 10.1016/j.gaceta.2009.06.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2009] [Revised: 05/29/2009] [Accepted: 06/28/2009] [Indexed: 11/15/2022]
Abstract
Lately Spain, the proportion of immigrants has increased in both general and HIV-infected populations. Nevertheles, data on the temporal trends of the epidemic in immigrants and on their sociodemographic, epidemiologic and clinical characteristics are scarce and are scattered in various information sources that cover complementary aspects of this issue. The objectives of the present study were to analyze the available information sources that allow the epidemiology of HIV infection in immigrants in Spain to be studied, and to describe the current situation of HIV infection in immigrants, based on the available information sources.
Collapse
Affiliation(s)
- Ana María Caro-Murillo
- Cohorte de la Red de Investigación en Sida (CoRIS), Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España.
| | | | | |
Collapse
|
31
|
Cameron A, Lloyd L, Turner W, Macdonald G. Working across boundaries to improve health outcomes: a case study of a housing support and outreach service for homeless people living with HIV. HEALTH & SOCIAL CARE IN THE COMMUNITY 2009; 17:388-395. [PMID: 19187420 DOI: 10.1111/j.1365-2524.2008.00837.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
This paper reports the findings of an evaluation of the 'Housing Support, Outreach and Referral' service developed to support people living with HIV who were homeless or at risk of homelessness. The service was set up as part of the Supporting People Health Pilot programme established to demonstrate the policy links between housing support services and health and social care services by encouraging the development of integrated services. The paper considers the role of housing support in improving people's health, and considers the challenges of working across housing, health and social care boundaries. The evaluation of the health pilot employed two main sources of data collection: quarterly project evaluation reports, which collected process data as well as reporting progress against aims and objectives, and semi-structured interviews with professionals from all key stakeholder groups and agencies, and with people who used services. Over the course of 15 months, 56 referrals were received of which 27 were accepted. Fifteen people received tenancy support of whom 12 were helped to access temporary accommodation. At the end of the 15 months, all of the tenancies had been maintained. In addition, 18 people registered with a general practitioner and 13 registered with an HIV clinic. Interviews with professionals emphasised the importance of the local joint working context, the involvement of the voluntary sector and the role of the support workers as factors that accounted for these outcomes. Those using services placed most emphasis on the flexibility of the support worker role. Importantly, interviews with professionals and those using services suggest that the role of support worker incorporates two dimensions--those of networker/navigator as well as advocate--and that both dimensions are important in determining the effectiveness of the service.
Collapse
Affiliation(s)
- Ailsa Cameron
- School for Policy Studies, University of Bristol, Bristol.
| | | | | | | |
Collapse
|
32
|
Collazos J, Asensi V, Cartón JA. CD4 responses in the setting or suboptimal virological responses to antiretroviral therapy: features, outcomes, and associated factors. AIDS Res Hum Retroviruses 2009; 25:647-55. [PMID: 19621987 DOI: 10.1089/aid.2008.0098] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The factors associated with discordant viroimmunological responses following antiretroviral therapy are unclear. We studied 1380 patients who initiated a protease inhibitor (PI)-based antiretroviral regimen and who fulfilled the criteria for inclusion. Of them, 255 (18.5%) had CD4 increases > or =100 cells/microl after 1 year of therapy despite detectable viral load (immunological responders); they were compared with 669 patients (48.5%) who had CD4 increases <100 cells/microl regardless of their final viral load (immunological nonresponders). Immunological responders had higher rates of sexual acquisition of HIV (p = 0.03), lower rates of clinical progression (p = 0.02), higher probabilities of being naive to antiretroviral therapy (p = 0.006) or to PI if antiretroviral experienced (p = 0.03), higher rates of receiving only nucleoside reverse transcriptase inhibitors in addition to the PI (p = 0.04), and lower baseline CD4 counts (p = 0.007) and higher viral loads (p = 0.009), as compared with nonresponders. Multivariate analysis revealed that sexual transmission of HIV (homosexual p = 0.004, heterosexual p = 0.03), no prior PI experience (p = 0.005), absence of clinical progression (p = 0.02), and lower baseline CD4 counts (p = 0.03) were independently associated with immunological response. However, these factors differed according to the patients' prior antiretroviral status, as higher baseline viral load was also associated with immunological response in antiretroviral-experienced patients (p = 0.02), whereas baseline CD4 count (p = 0.007) was the only predictive parameter in antiretroviral-naive patients. We conclude that immunological responses despite suboptimal viral suppression are common. Prior PI experience, HIV transmission category, baseline CD4 counts, and clinical progression were independently predictive of this condition, although the associated factors were different depending on the patient's prior antiretroviral history.
Collapse
Affiliation(s)
- Julio Collazos
- Infectious Disease Unit, Hospital de Galdácano-Usánsolo, Vizcaya, Spain
| | - Víctor Asensi
- Infectious Disease Unit, Hospital Central de Asturias, Oviedo, Spain
| | | |
Collapse
|
33
|
[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)]. Enferm Infecc Microbiol Clin 2009; 27:380-8. [PMID: 19427080 DOI: 10.1016/j.eimc.2008.10.007] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2008] [Revised: 10/09/2008] [Accepted: 10/24/2008] [Indexed: 11/22/2022]
Abstract
INTRODUCTION A growing number of immigrants are using the public health services for HIV in Spain. We describe the sociodemographic, epidemiological, and clinical characteristics of a cohort of naïve HIV-infected subjects (CoRIS cohort) according to their place of origin. METHODS CoRIS is an open, hospital-based cohort of naïve, HIV-infected persons attended in 19 hospitals from 9 of the 19 autonomous regions in Spain. We describe the characteristics of the cohort members by place of origin, and compare them with the Spanish cases identified from January 2004 to October 2006, using the chi-square and Fisher exact tests. RESULTS Of 2507 patients, 76.3% were men and median age was 36 years. By origin, 71.5% were Spanish, 16.0% Latin Americans (LA), 5.8% sub-Saharan Africans (SSA), 3.7% Western Europeans (WE), 1.7% Eastern Europeans (EE) and 1.4% North Africans (NA). Compared to Spaniards, there were significant differences by origin in sex, age, and transmission category. Median CD4 count at cohort entry was 352 cell/microL, with no differences according to origin. Median viral load was 48 962 copies/mL and was significantly lower for SSA. Over 11.4 months of follow-up, 57.9% initiated HAART with no differences by origin. Hepatitis C prevalence was 29.9% in Spaniards, 7.3% in Latin Americans, 11.7% in SSA, and 45.7% in EE (P<0.05). Overall, 13.4% were Mantoux-positive (28.6% in SSA and 30.8% in NA). Tuberculosis was more common among cases from EE (9.5%) and SSA (8.3%) compared to Spaniards (4.8%) (P<0.05). CONCLUSIONS Almost one third of naïve HIV-infected patients in CoRIS are foreign-born. Their sociodemographic, epidemiological and clinical characteristics reflect the epidemic in their places of origin. However, their immunological status at cohort entry and initiation of HAART is no different from that of Spaniards.
Collapse
|
34
|
Collazos J, Asensi V, Carton JA, Ibarra S, the Grupo Español para el Estudio M. The influence of the patients’ educational levels on socioeconomic, clinical, immunological and virological endpoints. AIDS Care 2009; 21:511-9. [DOI: 10.1080/09540120802270300] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Julio Collazos
- a Units of Infectious Diseases , Hospital de Galdácano-Usánsolo , Vizcaya , Spain
| | | | | | | | | |
Collapse
|
35
|
Regidor E, Sánchez E, de la Fuente L, Luquero FJ, de Mateo S, Domínguez V. Major reduction in AIDS-mortality inequalities after HAART: the importance of absolute differences in evaluating interventions. Soc Sci Med 2008; 68:419-26. [PMID: 19056156 DOI: 10.1016/j.socscimed.2008.10.039] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2008] [Indexed: 11/19/2022]
Abstract
This study estimates the magnitude of inequalities in AIDS mortality in the period when highly active antiretroviral therapy (HAART) was introduced and after its widespread dissemination in the Region of Madrid, Spain. Two population cohorts were constructed by linking records from 1996 and 2001 population censuses with mortality registry records after initial and full implementation of HAART, respectively. Absolute and relative differences in AIDS mortality in people aged 20-49 years were estimated in each population cohort according to neighbourhood and individual socioeconomic position. The absolute difference in mortality between neighbourhoods with highest and lowest socioeconomic position (unemployment rate, per capita income) declined from about 30/100,000 person-years in the 1996 population cohort to 8/100,000 person-years in the 2001 population cohort. The absolute difference in mortality between individuals with the highest and lowest socioeconomic position fell from about 60/100,000 person-years in the first cohort to about 20/100,000 in the second. Relative differences in mortality by neighbourhood socioeconomic position and by individual education level also decreased in the 2001 cohort with respect to the 1996 cohort. Although relative differences by individual occupation increased, there was no evidence of a significant change. These findings show major reduction in absolute socioeconomic differences in AIDS mortality after HAART and indicate that the use of relative differences alone may be inadequate to fully evaluate the results of health interventions.
Collapse
Affiliation(s)
- Enrique Regidor
- Department of Preventive Medicine and Public Health, Universidad Complutense de Madrid, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
| | | | | | | | | | | |
Collapse
|
36
|
What we can learn from the INSPIRE Study about improving prevention and clinical care for injection drug users living with HIV. J Acquir Immune Defic Syndr 2008; 46 Suppl 2:S31-4. [PMID: 18089982 DOI: 10.1097/qai.0b013e318157892d] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Perez-Hoyos S, Rodríguez-Arenas MA, García de la Hera M, Iribarren JA, Moreno S, Viciana P, Peña A, Gómez Sirvent JL, Saumoy M, Lacruz J, Padilla S, Oteo JA, Asencio R, Del Amo J. Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort. J Womens Health (Larchmt) 2007; 16:1052-61. [PMID: 17903082 DOI: 10.1089/jwh.2007.0437] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVE To study if progression to AIDS and death, as well as clinical and virological response to highly active antiretroviral therapy (HAART), differs between men and women. METHODS We studied a multicenter, hospital-based cohort of HIV-infected patients attending 10 hospitals in Spain from January 1997 to December 2003. Kaplan-Meier and Cox regression were used to assess the effect of sex on time to AIDS, survival from AIDS, onset of a new AIDS event or death, and viral suppression from HAART. RESULTS Of 4643 patients, 27% were women. Women had statistically significant lower viral loads (VL) of 3.9 vs. 4.1 log10/mL (p = 0.02) and higher median CD4 counts of 339 vs. 288 cells/mm3 (p < 0.001) at entry and were more likely to be AIDS free at entry. In univariate analysis, women seemed to show a nonsignificant lower progression to AIDS (HR 0.88) (95 CI% 0.73-1.07), which disappeared in multivariate analyses (HR 1.03) (95% CI 0.82-1.29). Survival from AIDS seemed to be higher in women (HR 0.65) (95% CI 0.40-1.05), but differences became clearly nonsignificant after adjustments (HR 0.71) (95% CI 0.42-1.23). No differences were seen in time to new AIDS condition or death after HAART (HR 1.08) (95% CI 0.80-1.46) in multivariate analyses. No differences were seen for time to VL suppression after initiation of HAART (HR 1.07) (95% CI 0.92-1.24). CONCLUSIONS We have found no differences in HIV progression and response to HAART attributable to gender among patients accessing the Spanish hospital network.
Collapse
|
38
|
Yokaichiya CM, Figueiredo WDS, Schraiber LB. Usuários de drogas injetáveis e terapia anti-retroviral: percepções das equipes de farmácia. Rev Saude Publica 2007; 41 Suppl 2:14-21. [DOI: 10.1590/s0034-89102007000900005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2006] [Accepted: 07/14/2007] [Indexed: 11/22/2022] Open
Abstract
OBJETIVO: Compreender as percepções das equipes de farmácia sobre seu papel nos desafios assistenciais e adesão aos anti-retrovirais de usuários de drogas injetáveis vivendo com HIV/Aids. MÉTODOS: Estudo qualitativo por grupos focais e análise temática das falas produzidas com farmacêuticos, técnicos e auxiliares com experiência superior a seis meses na dispensação de medicamentos, de 15 unidades assistenciais de DST/Aids do município de São Paulo, em 2002. RESULTADOS: Formaram-se três grupos, totalizando 29 participantes, provenientes de 12 dos 15 serviços existentes, com 12 universitários e 17 profissionais de nível médio. Os grupos concluíram que a farmácia tem importante papel na dispensação de anti-retrovirais, o que se reflete na adesão ao tratamento, pois por meio de seus procedimentos podem ser construídas relações de confiança. Avaliam, porém, que tal construção não ocorra pela excessiva burocratização de suas atividades. Isso repercute negativamente para todos os pacientes, em especial sobre usuários de drogas injetáveis, concebidos como "pessoas difíceis". Tal concepção essencializa seus comportamentos: seriam confusos, com limites de compreensão e sem possibilidades de adesão ao tratamento. Os profissionais, porém, afirmam que tratam esses pacientes tal como os demais, igualando-os. Não percebem neste proceder, uma invisibilização das necessidades específicas dos usuários de drogas injetáveis no serviço, bem como a possibilidade de gerarem estereótipos estigmatizantes com barreira adicional ao trabalho da adesão. CONCLUSÕES: Embora a farmácia seja indicada como espaço potencialmente favorável para escuta e construção de vínculos com os usuários, os resultados mostram obstáculos objetivos e subjetivos para torná-la propícia para trabalhar a adesão.
Collapse
|
39
|
Saliba B, Paraponaris A, Ventelou B. Situations à l'égard du travail des personnes atteintes de maladies chroniques. Rev Epidemiol Sante Publique 2007; 55:253-63. [PMID: 17604585 DOI: 10.1016/j.respe.2007.04.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2006] [Accepted: 04/05/2007] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND This paper is aimed at investigating the extents to which illness modifies labour supply and employment conditions of people with chronic diseases (defined as severe diseases giving rise to 100% coverage of health expenditures by the Sickness Fund). METHODS It is based on the data of 35073 individuals interviewed in the 2002-2003 French Decennial Health Survey, reporting their health, health care consumption and socioeconomic characteristics, and collected by the French National Institute of Statistics and Economic Studies. Models have been estimated with logistic strategies. RESULTS Participation in labour market appears, all other things being equal, to be less important for people with chronic diseases. Chronic diseases are more deleterious for blue collar than for white collars workers. The probability to have a part-time job is raised by 60% for people with chronic diseases (100% for men, 50% for women). Suffering from chronic diseases raises the probability to have a desired part-time job rather than a full-time job by 80% (170% for men, 60% for women) and the probability to have an undesired part-time job rather than a full-time job by 50% (30% for men, 50% for women). For the elderly (50-65 years), chronic diseases multiply by three the probability to be out-of-work (and not retired), by two the probability to be retired and by 1.5 the probability to be unemployed compared to being employed. CONCLUSION The consequences of chronic diseases on the workplace are not negligible, creating new social inequalities that the French social protection system does not seem to be able to completely cover.
Collapse
Affiliation(s)
- B Saliba
- Institut national de la santé et de la recherche médicale, UMR 379, Marseille, France
| | | | | |
Collapse
|
40
|
Marí-Dell'Olmo M, Rodríguez-Sanz M, Garcia-Olalla P, Pasarín MI, Brugal MT, Caylà JA, Borrell C. Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe. J Epidemiol Community Health 2007; 61:232-40. [PMID: 17325402 PMCID: PMC2652926 DOI: 10.1136/jech.2006.048017] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To study socioeconomic inequalities in AIDS mortality in Barcelona, Spain, during the periods 1991-6 (before highly active antiretroviral therapy (HAART)) and 1997-2001 (post-HAART) taking into account individual as well as community effects of socioeconomic level. DESIGN Cross-sectional design. SETTING Barcelona, Spain. PARTICIPANTS All residents aged > or =20 years. All AIDS-related deaths occurring between 1991 and 2001 were studied. The individual variables analysed were age, sex, educational level, neighbourhood of residence and HIV transmission group. Male unemployment was used as the community-level indicator of neighbourhood deprivation. Multilevel Poisson regression models were fitted to estimate the relationship between AIDS mortality and the individual- and community-level variables. RESULTS At the individual level, AIDS mortality relative risks (RR) were higher among intravenous drug users (IDUs) with lower educational level in both periods. For the younger population, the RR of AIDS-related mortality associated with having little education compared with having a primary education or more was 4.7 (95% CI 3.6 to 6.1) in men and 5.2 (95%CI 3.6 to 7.7) in women in the pre-HAART period, and 4.7 (95% CI 2.7 to 8.1) in men and 4.5 (95% CI 1.4 to 14.1) in women in the post-HAART period. At the community level, an area effect in AIDS mortality was found, which was more important in neighbourhoods having high deprivation in both periods, although the effect was most important in the post-HAART period. CONCLUSIONS This study has shown inequalities in AIDS mortality in terms of both individual variables and a community-level variable in the pre-HAART as well as in the post-HAART period. These socioeconomic inequalities of AIDS mortality must be considered when prevention and treatment strategies are implemented.
Collapse
Affiliation(s)
- Marc Marí-Dell'Olmo
- Agència de Salut Pública de Barcelona, Plaça Lesseps 1, 08023 Barcelona, Spain
| | | | | | | | | | | | | |
Collapse
|
41
|
Dray-Spira R, Gueguen A, Ravaud JF, Lert F. Socioeconomic differences in the impact of HIV infection on workforce participation in France in the era of highly active antiretroviral therapy. Am J Public Health 2007; 97:552-8. [PMID: 17267720 PMCID: PMC1805026 DOI: 10.2105/ajph.2005.081083] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES We sought to measure the difference in employment rates between HIV-seropositive and HIV-seronegative persons and to establish whether this difference varied according to the HIV-infected persons' socioeconomic position as defined by education level. METHODS We used data from the VESPA (VIH: Enquête Sur les Personnes Atteintes) study, a large cross-sectional survey conducted among a nationally representative sample of 2932 HIV-infected patients in France. Age-, gender-, nationality-, and education-standardized employment rates were estimated with the French general population as the reference. The differences in employment rates with the general population were computed overall and according to education level. RESULTS Compared with that of the general population, the overall employment rate was 25% lower (95% confidence interval [CI]=16%, 32%) among HIV-infected patients diagnosed before 1994 and 9% lower (95% CI = 5%, 16%) among HIV-infected patients diagnosed from 1994 onward. The difference in employment rates with the general population was significantly higher among patients with a low education level. The employment rate of highly educated HIV-infected patients diagnosed from 1994 onward did not differ from that of the general population. CONCLUSIONS HIV infection was associated with decreased workforce participation among those with a low education level but not among highly educated individuals.
Collapse
Affiliation(s)
- Rosemary Dray-Spira
- Institut National de la Santé et la Recerche Médicale, Unit 687, Saint-Maurice, France.
| | | | | | | |
Collapse
|
42
|
Dray-Spira R, Lert F. Living and working with HIV in France in 2003: results from the ANRS-EN12-VESPA Study. AIDS 2007; 21 Suppl 1:S29-36. [PMID: 17159584 DOI: 10.1097/01.aids.0000255082.31728.52] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES The employment rate of people living with HIV in France remains lower than in the general population despite HAART (highly active antiretroviral therapy) availability, translating into a high disease-related socioeconomic burden. Our objective was to investigate the relationships between HIV disease and employment status. DESIGN We used data from the ANRS-EN12-VESPA Study. METHODS Analyses were restricted to the 2750 working-aged (<60 years) participants. Individuals' health characteristics were compared according to employment status and plans of access/return to work, using logistic regression models to account for sociodemographic/occupational and health characteristics. RESULTS The employment rate was 56.5%; 44.9% of participants had remained employed since diagnosis and 11.6% had accessed employment after diagnosis. Compared with unemployed participants, those who had maintained employment were less likely to be of fair/poor health and have a history of AIDS and hepatitis C virus co-infection, were more likely to have been diagnosed with HIV after 1996, have a history of HIV-related hospitalization and a CD4 cell count of 200 cells/microl or less. Among employed participants, 70.1% had not disclosed their HIV status at the workplace and 8.5% reported HIV-related adjustments in their working conditions. Among the unemployed, 64.5% reported plans of access/return to work and 58.2% of those had attempted to do so. Motivations for access/return to work were mainly of a social, psychological and financial nature. CONCLUSION The employment status of people living with HIV/AIDS is associated with sociodemographic/occupational factors in addition to health characteristics. Management of HIV infection at work remains a challenge in the HAART era.
Collapse
|
43
|
Rodríguez-Arenas MA, Jarrín I, del Amo J, Iribarren JA, Moreno S, Viciana P, Peña A, Sirvent JLG, Vidal F, Lacruz J, Gutierrez F, Oteo JA, Asencio R, Castilla J, Hoyos SP. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain. AIDS Res Hum Retroviruses 2006; 22:715-23. [PMID: 16910826 DOI: 10.1089/aid.2006.22.715] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Differences in the uptake and time to initiation of highly active antiretroviral therapy (HAART), the virological response to HAART, and survival from AIDS by transmission category were analyzed. A multicenter hospital-based cohort of HIV-infected patients attending 10 hospitals in Spain from January 1997 to December 2003 was used. Cross-checks with the National AIDS Registry were performed. Cox proportional hazard models were used to assess the impact of transmission category on time to HAART initiation, viral suppression (defined by first HIV-1 RNA viral load measurement <500 copies/ml after HAART), and survival from AIDS. Of 4643 patients, 73% were men and 56% were injecting drug users (IDUs). A statistically significant interaction was found between transmission category and previous non-HAART antiretroviral treatment (ART) (p < 0.05). Among ART naive patients, IDUs had a 33% lower risk of initiating HAART compared to men who have sex with men (MSM) [HR 0.67 (95% CI 0.57-0.79)]. No differences by transmission categories were seen among patients with prior non-HAART ART. IDUs had poorer viral load (VL) suppression than MSM [HR 0.86 (95% CI 0.74-0.99)] adjusting by baseline VL, AIDS diagnosis, and prior ART. Mortality from AIDS was two and a half times higher in IDUs than MSM [HR 2.51 (95% CI 1.03-6.1)]. Among patients who access the hospital network, IDUs have a lower uptake of HAART, have worse virological suppression, and have higher mortality after AIDS diagnosis. There is a need to extend the programs in order to enhance access and adherence of IDUs to HAART and consider the treatment of drug addiction as an integral part of the treatment for HIV infection.
Collapse
|
44
|
Borrell C, Rodríguez-Sanz M, Pasarín MI, Brugal MT, García-de-Olalla P, Marí-Dell'Olmo M, Caylà J. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System? Eur J Public Health 2006; 16:601-8. [PMID: 16698886 DOI: 10.1093/eurpub/ckl062] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The aim of this study is to determine whether socioeconomic AIDS mortality inequalities before and after the introduction of highly active antiretroviral therapy (HAART) have increased or decreased in a Spanish city where HAART is free. METHODS The study used a trend design, including all Barcelona residents older than 19 years of age. All AIDS deaths, which occurred among these residents between 1991 and 2001 were included. The variables studied were age, sex, socioeconomic (SES) group and HIV transmission group. AIDS age-standardized mortality rates for each year were estimated. Poisson regression models were fitted to obtain the relative risk (RR) of AIDS death for each socioeconomic group with respect to the reference group. RESULTS AIDS mortality increased up until 1995 and subsequently decreased due to the introduction of HAART. The increase in AIDS mortality was greater in the lowest SES group, which had higher rates and a RR of dying larger than that of the highest SES group, fact that remained fairly stable over the whole period. A similar pattern was observed in intravenous drug users. In the homosexual transmission group, rates for the lowest SES group were higher for the whole period and increased until 1996, while rates for the other SES groups were lower and decreased over the entire period. CONCLUSIONS The fact that inequalities in AIDS mortality by SES group remained fairly stable for the whole period suggests that perhaps access to HAART, or adherence, is lower than desirable, in people of lower SES groups. These results ought to be taken into account when implementing treatment and prevention strategies.
Collapse
Affiliation(s)
- Carme Borrell
- Agència de Salut Pública de Barcelona, Red de Centros de Epidemiología y Salud Pública, Barcelona, Spain.
| | | | | | | | | | | | | |
Collapse
|
45
|
Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, Montaner JSG, Hogg RS. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS 2006; 20:445-50. [PMID: 16439879 DOI: 10.1097/01.aids.0000206508.32030.92] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
BACKGROUND The introduction of HAART has led to consistent improvements in survival among HIV-infected individuals. However, there is evidence that not all populations have benefited equally from HAART and that mortality rates are higher in HIV-infected injection drug users than in non-users. OBJECTIVE To model life expectancies for HIV-positive individuals subdivided according to history of injection drug use and treatment with HAART. DESIGN Population-based study of HIV-positive persons in British Columbia's HIV/AIDS treatment program. METHODS The primary outcome measures in this study were life expectancy at exact age 20 and potential years of life lost. RESULTS The highest life expectancy (38.9 years) and lowest potential years of life lost were measured for individuals taking HAART and without a history of injection drug use. The lowest life expectancy (19.1 years) and highest potential years of life lost were measured in HIV-positive injection drug users who were not taking HAART. CONCLUSIONS There are substantial disparities in life expectancy for persons living with HIV in British Columbia. Members of the injection drug community, particularly those who are not taking HAART, experience elevated mortality in comparison with those without a history of drug use.
Collapse
Affiliation(s)
- Elisa Lloyd-Smith
- Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
| | | | | | | | | | | | | |
Collapse
|
46
|
Dray-Spira R, Gueguen A, Persoz A, Deveau C, Lert F, Delfraissy JF, Meyer L. Temporary employment, absence of stable partnership, and risk of hospitalization or death during the course of HIV infection. J Acquir Immune Defic Syndr 2005; 40:190-7. [PMID: 16186737 DOI: 10.1097/01.qai.0000165908.12333.4e] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To estimate the independent association between socioeconomic conditions and the risk of all-cause hospitalization or death during the course of HIV disease in the highly active antiretroviral therapy (HAART) era. METHODS Patients in the French PRIMO multicenter prospective cohort of 319 individuals were enrolled during primary HIV-1 infection between 1996 and 2002. Associations between social characteristics (ie, employment status, stable partnership) and the risk of hospitalization or death were assessed using generalized estimating equations. RESULTS During a median follow-up of 2.5 years, 109 hospitalizations among 84 patients (26.3%) and 3 deaths occurred. Even after adjustment for classic determinants of HIV-infected patients' health status, social characteristics were independently associated with the risk of hospitalization or death, with a significantly increased risk for patients with temporary employment compared with those with stable employment (adjusted odds ratio [OR] = 2.5, 95% confidence interval: 1.1 to 5.6) and for patients without a stable partnership compared with those with a stable partnership (OR = 1.6, 95% confidence interval: 1.0 to 2.7). CONCLUSIONS In the era of HAART, adverse social conditions constitute independent risk factors of hospitalization or death during the course of HIV disease.
Collapse
Affiliation(s)
- Rosemary Dray-Spira
- INSERM U687-IFR69, Hôpital National de Saint-Maurice, Saint-Maurice Cedex, France.
| | | | | | | | | | | | | |
Collapse
|
47
|
Chee CC, Mortier E, Dupont C, Bloch M, Simonpoli AM, Rouveix E. Medical and social differences between French and migrant patients consulting for the first time for HIV infection. AIDS Care 2005; 17:516-20. [PMID: 16036237 DOI: 10.1080/09540120412331291760] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
The objectives of the study were to describe the medical and social characteristics of patients consulting for the first time after diagnosis of HIV-infection and to compare the medical and social characteristics between French and migrant patients. From 1 January 2001 to 31 December 2002, all consecutive adults consulting for the first time for HIV infection in two HIV outpatient clinics located in the western suburb of Paris, agreed to an interview based on an administered questionnaire regarding their medical and socioeconomic characteristics. Of the 203 patients (98 women, 105 men), one-third (n=70) was of French nationality. Delay (+/-SD) in access to HIV outpatient clinic after diagnosis was shorter in migrant than in French patients, respectively 7.6+/-29.6 months (median=0.5, range=0 to 196.6) and 23.8+/-51.4 months (median=0.9, range=0 to 199.7); p=0.005. There was no significant difference in the medical characteristics between the two groups of patients on their first consultation. However, most of the migrants were living in very poor socio-economic conditions with minimal resources thus sometimes delaying initiation of HAART. The development of social facilities for HIV-positive migrants should be a public health priority.
Collapse
Affiliation(s)
- C C Chee
- MGEN-Foundation for Public Health, Paris, France
| | | | | | | | | | | |
Collapse
|
48
|
Saracino A, El-Hamad I, Prato R, Cibelli DC, Tartaglia A, Palumbo E, Pezzoli MC, Angarano G, Scotto G. Access to HAART in HIV-infected immigrants: a retrospective multicenter Italian study. AIDS Patient Care STDS 2005; 19:599-606. [PMID: 16164386 DOI: 10.1089/apc.2005.19.599] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Since 1996, AIDS has declined in the Italian population, but cases in foreign patients, including both recent immigrants and long-term residents, have increased from 3.9% in 1995-1996 to 15.4% in 2001-2002. This increase can only be partly explained by a higher migratory flow and might reflect a delayed access to health facilities and to antiretroviral therapy in migrants. We performed a survey for the year 2003 of HIV-infected immigrants to Italy from countries outside the European Union to verify which factors might influence a lack of access to highly active antiretroviral therapy (HAART). Italian centers of infectious diseases were requested to send sociodemographic and clinical data of HIV-infected immigrant patients. A total of 553 HIV-infected immigrants (49.9% women) were evaluated, representing 6.5% of all HIV-infected patients from these centers. The mean duration of residency in Italy was 6.6 +/- 5.0 years. The country of origin was Africa (64.5%), North and South America (24.2%), Eastern Europe (7.0%), and Asia (3.8%). A total of 407 of 553 patients (73.6%) were taking antiretroviral drugs at the time of screening. Females presented a younger age (p = 0.001), a lower frequency of Centers for Disease Control (CDC) stage B/C (p = 0.008) and a more frequent heterosexual exposure to HIV (p < 0.001), while no differences were observed for time of first positive serology (p = 0.7). CD4 cell count (p = 0.9) and log plasma HIV-RNA (p = 0.1). Characteristics of HAART patients were compared to those of nontreated patients, despite a CD4 cell count less than 350 cells/mm(3). No significant difference was found for gender, country of origin, risk factor, and years of Italian residence, while legal immigrants (p = 0.018) and registered in the National Health Service (p = 0.014) were significantly more likely to receive HAART compared to illegal immigrants.
Collapse
Affiliation(s)
- A Saracino
- Clinic of Infectious Diseases, University of Foggia, v.le L Pinto, 1-71100 Foggia, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Harding R, Easterbrook P, Higginson IJ, Karus D, Raveis VH, Marconi K. Access and equity in HIV/AIDS palliative care: a review of the evidence and responses. Palliat Med 2005; 19:251-8. [PMID: 15920940 DOI: 10.1191/0269216305pm1005oa] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The high prevalence of pain and other symptoms throughout the HIV disease trajectory, the need for management of side effects related to antiretroviral therapy, the continuing incidence of cancers and new emerging co-morbidities as a result of extended life expectancy under new therapeutic regimes, and the ongoing need for terminal care all prove the curative versus palliative dichotomy to be inappropriate. Although there is evidence for both need and effectiveness of palliative care in HIV patient care, access is often poor and care less than optimal. This review aimed to identify evidence of barriers and inequalities in HIV palliative care in order to inform policy and service development. Biomedical databases were searched using a specific strategy, and evidence extracted into the barrier and inequity categories of patient, clinician, service and disease factors. A model of the barriers and inequalities is presented from the evidence. Recommendations are made from the evidence for promoting access and outcomes through integrated palliative care from diagnosis to end-of-life, alongside antiretroviral therapy when initiated. Service responses that have attempted to increase access to palliative care are presented.
Collapse
Affiliation(s)
- Richard Harding
- Department of Palliative Care and Policy, GKT Medical School, King's College London, Weston Education Centre, London SE5 9RJ, UK.
| | | | | | | | | | | |
Collapse
|
50
|
García de la Hera M, Ferreros I, del Amo J, García de Olalla P, Pérez Hoyos S, Muga R, del Romero J, Guerrero R, Hernández-Aguado I. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. J Epidemiol Community Health 2005; 58:944-50. [PMID: 15483312 PMCID: PMC1732603 DOI: 10.1136/jech.2003.017475] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Although the consensus is that gender does not influence HIV progression, its relevance may depend on the setting. AIM To study gender differences in HIV progression to AIDS and death from 1986 to 2001 in a cohort of injecting drug user (IDU) seroconverters in Spain. METHODS Risk of AIDS and death in persons infected for the same length of time were compared through Kaplan-Meier, allowing for late entry, and Cox regression adjusting for gender, age, and calendar period (before 1992, 1992-1995, 1996-1998, 1999-2001) fitted as time dependent covariates. RESULTS Of 929 IDU, 24.7% were women. Median seroconversion year was 1993.3 for men and women. 44% of women and 34% of men received antiretroviral therapy. Risk of AIDS was lower in women in univariate (hazard ratio (HR) 0.72; 95%CI:0.51 to 1.01) and multivariate analyses (HR 0.73 95%CI:0.52 to 1.03). A 46% reduction in risk of AIDS for period 1999-2001 compared with 1992-1995 was seen in both men and women (HR: 0.56 (95%CI:0.36 to 0.87). As for mortality, women's risk of death was lower univariately (HR 0.67 95%CI:0.45 to 0.99) although compared with 1992-95, men experienced a 34% reduction in mortality during 1999-2001 (HR 0.66 95%CI:0.40 to 1.01), which was not statistically significant in women. CONCLUSIONS HIV progression was lower in female IDU before and after 1997 and their uptake of antiretroviral therapy was higher than male IDU. The inability to detect a reduction in mortality for women during 1999-2001 is probably attributable to lack of power. Differences in severity of addiction, drug using patterns, and competing causes of death may explain these findings.
Collapse
|